drugset / Trial / NCT00344253
Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to investigate if interferon beta is superior to the standard treatment with Methotrexate for the treatment of intermediate uveitis and macular edema.
Timeline
- Start
- 2006-03
- Primary completion
- 2011-03
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon-beta | Protein / enzyme biologic | — | — |
| Comparator | Methotrexate | Small molecule | 20 mg | Subcutaneous |